AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-0.63%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$145M
AUM Growth
+$145M
(+43%)
Cap. Flow
+$38.3M
Cap. Flow
% of AUM
26.41%
Top 10 Holdings %
Top 10 Hldgs %
24.02%
Holding
223
New
58
Increased
34
Reduced
85
Closed
14
Top Buys
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$6.33M |
| 2 |
Centene
CNC
|
$3.16M |
| 3 |
Invesco QQQ Trust
QQQ
|
$2.81M |
| 4 |
Invesco NASDAQ 100 ETF
QQQM
|
$2.81M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$2.46M |
Top Sells
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$3.01M |
| 2 |
PennyMac Financial
PFSI
|
$1.76M |
| 3 |
AirSculpt Technologies
AIRS
|
$1.33M |
| 4 |
Starwood Property Trust
STWD
|
$1.19M |
| 5 |
Ametek
AME
|
$1.05M |
Sector Composition
| 1 | Healthcare | 56.03% |
| 2 | Real Estate | 10.47% |
| 3 | Financials | 4.37% |
| 4 | Energy | 4.28% |
| 5 | Technology | 2.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insmed
INSM
$30.3B
| $1.44M | 0.99% |
84,500
+64,500
| +323% | +$1.1M |
|
|
DX
27
Dynex Capital
DX
$1.64B
| $1.44M | 0.99% |
118,590
+35,000
| +42% | +$424K |
|
28
Procept Biorobotics
PRCT
$2.11B
| $1.42M | 0.98% |
50,000
| – | – |
|
|
ITCI
29
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.38M | 0.95% |
25,500
+18,000
| +240% | +$975K |
|
30
AeroVironment
AVAV
$11.9B
| $1.37M | 0.95% |
15,000
| – | – |
|
31
Allient
ALNT
$757M
| $1.35M | 0.93% |
35,000
-2,500
| -7% | -$96.6K |
|
32
Intuitive Surgical
ISRG
$158B
| $1.28M | 0.88% |
5,000
| – | – |
|
33
Alkermes
ALKS
$4.95B
| $1.27M | 0.88% |
+45,000
| New | +$1.27M |
|
34
Fulgent Genetics
FLGT
$674M
| $1.23M | 0.85% |
39,500
| – | – |
|
35
Collegium Pharmaceutical
COLL
$1.25B
| $1.19M | 0.82% |
49,500
| – | – |
|
|
AMYT
36
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $1.18M | 0.82% |
81,000
| – | – |
|
37
Ultragenyx Pharmaceutical
RARE
$3.04B
| $1.14M | 0.79% |
28,500
+1,500
| +6% | +$60.2K |
|
38
Stereotaxis
STXS
$247M
| $1.12M | 0.77% |
550,000
+50,000
| +10% | +$102K |
|
|
DCPH
39
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.12M | 0.77% |
+72,500
| New | +$1.12M |
|
|
VRNA
40
Verona Pharma
VRNA
$9.18B
| $1.1M | 0.76% |
55,000
| – | – |
|
|
PETQ
41
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.09M | 0.75% |
95,000
| – | – |
|
42
Mobileye
MBLY
$11.1B
| $1.08M | 0.75% |
25,000
| – | – |
|
43
Dynavax Technologies
DVAX
$1.19B
| $1.05M | 0.73% |
107,500
+71,500
| +199% | +$701K |
|
44
Accuray
ARAY
$165M
| $1.04M | 0.72% |
350,000
| – | – |
|
45
Novavax
NVAX
$1.2B
| $1.04M | 0.72% |
150,000
+45,000
| +43% | +$312K |
|
46
DocGo
DCGO
$152M
| $1.04M | 0.72% |
120,000
+10,000
| +9% | +$86.5K |
|
47
Jazz Pharmaceuticals
JAZZ
$7.99B
| $1.02M | 0.71% |
7,000
+3,500
| +100% | +$512K |
|
|
RWT
48
Redwood Trust
RWT
$793M
| $988K | 0.68% |
146,593
+15,195
| +12% | +$102K |
|
|
WBA
49
DELISTED
Walgreens Boots Alliance
WBA
| $968K | 0.67% |
28,000
+16,000
| +133% | +$553K |
|
|
ONIT
50
Onity Group Inc.
ONIT
$339M
| $966K | 0.67% |
35,618
| – | – |
|